These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15207989)

  • 1. Processes of care in cervical and breast cancer screening and follow-up--the importance of communication.
    Zapka JG; Puleo E; Taplin SH; Goins KV; Ulcickas Yood M; Mouchawar J; Somkin C; Manos MM
    Prev Med; 2004 Jul; 39(1):81-90. PubMed ID: 15207989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence characteristics after abnormal screening results between mammogram and Papanicolaou test groups.
    Fang SY; Shu BC
    Cancer Nurs; 2009; 32(6):437-45. PubMed ID: 19816157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for care related to follow-up of abnormal cancer screening tests: accuracy of patient report.
    Puleo E; Zapka JG; Goins KV; Yood MU; Mouchawar J; Manos M; Somkin C; Taplin S
    Eval Health Prof; 2005 Sep; 28(3):310-27. PubMed ID: 16123260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in abnormal cancer screening results in the United States of America.
    Yabroff KR; Freedman A; Brown ML; Ballard-Barbash R; McNeel T; Taplin S
    J Med Screen; 2007; 14(2):67-72. PubMed ID: 17626704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey.
    Yabroff KR; Breen N; Vernon SW; Meissner HI; Freedman AN; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):723-32. PubMed ID: 15159302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in predictors of cervical and breast cancer screening by screening need in uninsured Latino women.
    Buki LP; Jamison J; Anderson CJ; Cuadra AM
    Cancer; 2007 Oct; 110(7):1578-85. PubMed ID: 17696119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast and cervical cancer screening in Spain and predictors of adherence.
    Martín-López R; Hernández-Barrera V; De Andres AL; Garrido PC; De Miguel AG; García RJ
    Eur J Cancer Prev; 2010 May; 19(3):239-45. PubMed ID: 20110817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician recommendation for papanicolaou testing among U.S. women, 2000.
    Coughlin SS; Breslau ES; Thompson T; Benard VB
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
    Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
    J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast and cervical cancer screening in an inner-city medical walk-in clinic: taking advantage of an often missed opportunity.
    Doyle JP; Parker RM; Jacobson TA; McNagny SE
    Am J Prev Med; 1996; 12(5):345-50. PubMed ID: 8909645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What predicts adherence to follow-up recommendations for abnormal Pap tests among older women?
    Coker AL; Eggleston KS; Meyer TE; Luchok K; Das IP
    Gynecol Oncol; 2007 Apr; 105(1):74-80. PubMed ID: 17157363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of citizenship status, acculturation, and health insurance in breast and cervical cancer screening among immigrant women.
    Echeverria SE; Carrasquillo O
    Med Care; 2006 Aug; 44(8):788-92. PubMed ID: 16862042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations in breast and colon cancer screening behavior in women.
    Carlos RC; Fendrick AM; Patterson SK; Bernstein SJ
    Acad Radiol; 2005 Apr; 12(4):451-8. PubMed ID: 15831418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of women's self-reports of cancer screening test utilization in a managed care population.
    Caplan LS; McQueen DV; Qualters JR; Leff M; Garrett C; Calonge N
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1182-7. PubMed ID: 14652278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast and cervical cancer screening: clinicians' views on health plan guidelines and implementation efforts.
    Zapka JG; Puleo E; Taplin S; Solberg LI; Mouchawar J; Somkin C; Geiger AM; Ulcickas Yood M
    J Natl Cancer Inst Monogr; 2005; (35):46-54. PubMed ID: 16287885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAPRELA (Cancer Prevention for Latinas): findings of a pilot study in Winston-Salem, Forsyth County.
    Koval AE; Riganti AA; Foley KL
    N C Med J; 2006; 67(1):9-15. PubMed ID: 16550986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal Pap screening among Mexican-American women: impediments to receiving and reporting follow-up care.
    Hunt LM; de Voogd KB; Akana LL; Browner CH
    Oncol Nurs Forum; 1998; 25(10):1743-9. PubMed ID: 9826840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of intent to seek unnecessary pap tests among elderly women.
    Zhang Y; Borders TF; Rohrer JE
    Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women's mammography experience and its impact on screening adherence.
    Tang TS; Patterson SK; Roubidoux MA; Duan L
    Psychooncology; 2009 Jul; 18(7):727-34. PubMed ID: 19035468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.